Heparin-binding epidermal growth factor-like growth factor: A component in chromaffin granules which promotes the survival of nigrostriatal dopaminergic neurones in vitro and in vivo

Neuroscience

Volumn 124, Issue 4, 2004, Pages 757-766

  Hanke, M ^a   Farkas, L M ^b,d   Jakob, M ^a   Ries, R ^a   Pohl, J ^a   Sullivan, A M ^c  

^a Biopharm GmbH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

Author keywords

Bovine serum albumin; BSA; DAB; Diaminobenzidine; Dithiothreitol; DMEM; Dopamine; DTT; Dulbecco's Modified Eagle medium; EGF; Heparin binding epidermal growth factor like growth factor (HB EGF); Neurotrophic factor; Parkinson's disease; Rat

Indexed keywords

COMPLEMENTARY DNA; DOPAMINE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ADRENAL GLAND; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATTLE; CELL SURVIVAL; CHROMAFFIN GRANULE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; MALE; MEDIAL FOREBRAIN BUNDLE; MESENCEPHALON; MOLECULAR CLONING; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SURVIVAL TIME;

AMINO ACID SEQUENCE; AMPHETAMINE; ANIMALS; BASE SEQUENCE; BEHAVIOR, ANIMAL; CATTLE; CELL SURVIVAL; CELLS, CULTURED; CHROMAFFIN GRANULES; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; EPIDERMAL GROWTH FACTOR; MOLECULAR SEQUENCE DATA; NEURONS; RATS; RATS, WISTAR; STEREOTYPED BEHAVIOR; SUBSTANTIA NIGRA;

EID: 1542321110     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2003.12.033     Document Type: Article

References (69)

1. Adamson E.D., Meek J. The ontogeny of epidermal growth factor receptors during mouse development. Dev Biol. 103:1984;62-70.
2. Backlund E.-O., Granberg P.-O., Hamberger B., Knutsson E., Martensson A., Sedvall G., Seiger A., Olson L. Transplantation of adrenal medullary tissue to striatum in parkinsonism First clinical trials. J Neurosurg. 62:1985;169-173.
3. Bankiewicz K.S., Plunkett R.J., Kophin I.J., Jacobowitz D.M., London W.T., Oldfield E.H. Transient behavioral recovery in hemiparkinsonian primates after adrenal medullary autografts. Prog Brain Res. 78:1988;543-550.
4. Barker R., Dunnett S. The biology and behaviour of intracerebral adrenal transplants in animals and man. Rev Neurosci. 4:1993;113-146.
5. Becker J.B., Freed W.J. Adrenal medulla grafts enhance functional activity of the striatal dopamine system following substania nigra lesions. Brain Res. 462:1988;401-406.
6. Bohn M.C., Cupit L., Marciano F., Gash D.M. Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science. 237:1987;913-916.
7. Carpenter G., Wahl M.I. The epidermal growth factor family. Sporn M.B., Roberts A.B. Peptide growth factors and their receptors. 1990;69-171 Springer-Verlag, Heidelberg.
8. Coulter C.L., McMillen I.C., Browne C.A. The catecholamine content of the perinatal rat adrenal gland. Gen Pharmacol. 19:1988;825-828.
9. Date I. Parkinson's disease, trophic factors, and adrenal medullary chromaffin cell grafting Basic and clinical studies. Brain Res Bull. 40:1996;1-19.
10. Date I., Felten S.Y., Olschowka J.A., Felten D.L. Limited recovery of striatal dopaminergic fibres by adrenal medullary grafts in MPTP-treated aging mice. Exp Neurol. 107:1990;197-207.
11. Date I., Imaoka T., Miyoshi Y., Ono T., Asari S., Ohmoto T. Chromaffin cell survival and host dopaminergic fiber recovery in a patient with Parkinson's disease treated by cografts of adrenal medulla and pretransected peripheral nerve Case report. J Neurosurg. 84:1996;685-689.
12. Derynck R., Roberts A.B., Winkler M.E., Chen E.Y., Goeddel D.V. Human transforming growth factor-alpha Precursor structure and expression in e. coli. Cell. 38:1984;287-297.
13. Donnan G.A., Woodhouse D.G., Kaczmarczyk S.J., Holder J.E., Paxinos G., Chilco P.J., Churchyard A.J., Kalnins R.M., Fabinyi G.C., Mendelsohn F.A. Evidence for plasticity of the dopaminergic system in parkinsonism. Mol Neurobiol. 5:1991;421-433.
14. Faber-Elman A., Solomon A., Abraham J.A., Marikovsky M., Schwartz M. Involvement of wound-associated factors in rat brain astrocyte migratory response to axonal injury In vitro stimulation. J Clin Invest. 97:1996;162-171.
15. Farkas L.M., Krieglstein K. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) regulates survival of midbrain dopaminergic neurons. J Neural Transm. 109:2002;267-277.
16. Fiandaca M.S., Kordower J.H., Hansen J.T., Jiao S.-S., Gash D.M. Adrenal medullary autografts into the basal ganglia of cebus monkeys Injury-induced regeneration. Exp Neurol. 102:1988;76-91.
17. Fine A. Transplantation of adrenal tissue into the central nervous system. Brain Res Rev. 15:1990;121-133.
18. Freed W.J., Karoum F., Spoor H.E., Morihisa J.M., Olson L., Wyatt R.J. Catecholamine content of intracerebral adrenal medulla grafts. Brain Res. 269:1983;184-189.
19. Freed W.J., Morihisa J.M., Spoor E., Hoffer B.J., Olson L., Seiger A., Wyatt R.J. Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behaviour. Nature. 292:1981;351-352.
20. Freed W.J., Poltorak M., Becker J.B. Intracerebral adrenal medulla grafts A review. Exp Neurol. 110:1990;139-166.
21. Goetz C.G., Olanow C.W., Koller W.C., Penn R.D., Cahill D., Morantz R., Stebbins G., Tanner C.M., Klawans H.L., Shannon K.M., Comella C.L., Witt T., Cox C., Waxman M., Gauger L. Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. N Engl J Med. 320:1989;337-341.
22. Goetz C.G., Stebbins G.T.I., Klawans H.L., Koller W.C., Grossman R.G., Bakay R.A.E., Penn R.D. United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants Presurgical, and 1- and 2-year follow-up. Neurology. 41:1991;1719-1722.
23. Gomez-Pinilla F., Knauer D.J., Nieto-Sampedro M. Epidermal growth factor receptor immunoreactivity in rat brain Development and cellular localization. Brain Res. 438:1988;385-390.
24. Guttman M. Dopamine receptors in Parkinson's disease. Neurol Clin. 10:1992;377-386.
25. Hansen J.T., Kordower J.H., Fiandaca M.S., Jiao S.S., Notter M.F., Gash D.M. Adrenal medullary autografts into the basal ganglia of cebus monkeys Graft viability and fine structure. Exp Neurol. 102:1988;65-75.
26. Hayase Y., Higashiyama S., Sasahara M., Amano S., Nakagawa T., Taniguchi N., Hazama F. Expression of heparin-binding epidermal growth factor-like growth factor in rat brain. Brain Res. 784:1998;163-178.
27. Herrera-Marschitz M., Stromberg I., Olsson D., Ungerstedt U., Olson L. Adrenal medullary implants in the dopamine-denervated rat striatum Ii. acute behavior as a function of graft amount and location and its modulation by neuroleptics. Brain Res. 297:1984;53-61.
28. Higashiyama S., Abraham J.A., Miller J., Fiddes J.C., Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science. 251:1991;936-939.
29. Hiramatsu M., Kashimata M., Sato A., Murayama M., Minami N. Influence of age on epidermal growth factor receptor level in the rat brain. Experientia. 44:1988;23-25.
30. Hirsch E.C., Duyckaerts C., Javoy-Agid F., Hauw J.J., Agid Y. Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease? Ann Neurol. 27:1990;676-682.
31. Howard C.V., Reed M.G. Unbiased stereology. 1998;Bios Scientific Publishers, Oxford, UK.
32. Hurtig H., Joyce J., Sladek J.R., Trojanowski J.Q. Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson's disease. Ann Neurol. 25:1989;607-614.
33. Iwamoto R., Mekada E. Heparin-binding EGF-like growth factor A juxtacrine growth factor. Cytokine Growth Factor Rev. 11:2000;335-344.
34. Jankovic J., Grossman R., Goodman C., Pirozzolo F., Schneider L., Zhu Z., Scardino P., Garber A.J., Jhingran S.G., Martin S. Clinical, biochemical, and neuropathological findings following transplantation of adrenal medulla to the caudate nucleus for treatment of Parkinson's disease. Neurology. 39:1989;1227-1234.
35. Jin K., Mao X.O., Sun Y., Xie L., Jin L., Nishi E., Klagsbrun M., Greenberg D.A. Heparin-binding epidermal growth factor-like growth factor Hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo. J Neurosci. 22:2002;5365-5373.
36. Jordan J., Bottner M., Schluesener H.J., Unsicker K., Krieglstein K. Bone morphogenetic proteins Neurotrophic roles for midbrain dopaminergic neurons and implications of astroglial cells. Eur J Neurosci. 9:1997;1699-1710.
37. Kawahara N., Mishima K., Higashiyama S., Taniguchi N., Tamura A., Kirino T. The gene for heparin-binding epidermal growth factor-like growth factor is stress-inducible Its role in cerebral ischemia. J Cereb Blood Flow Metab. 19:1999;307-320.
38. Kordower J.H., Cochran E., Penn R.D., Goetz C.G. Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease. Ann Neurol. 29:1991;405-412.
39. Kornblum H.I., Hussain R.J., Bronstein J.M., Gall C.M., Lee D.C., Seroogy K.B. Prenatal ontogeny of the epidermal growth factor receptor and its ligand, transforming growth factor alpha, in the rat brain. J Comp Neurol. 380:1997;243-261.
40. Kornblum H.I., Zurcher S.D., Werb Z., Derynck R., Seroogy K.B. Multiple trophic actions of heparin-binding epidermal growth factor (HB-EGF) in the central nervous system. Eur J Neurosci. 11:1999;3236-3246.
41. Krieglstein K., Henheik P., Farkas L., Jaszai J., Galter D., Krohn K., Unsicker K. Glial cell line-derived neurotrophic factor requires transforming growth factor-b for exerting its full neurotrophic potential on peripheral and CNS neurons. J Neurosci. 18:1998;9822-9834.
42. Krieglstein K., Unsicker K. Protein from chromaffin granules promotes survival of mesencephalic dopaminergic neurons by an EGF-receptor ligand-mediated mechanism. J Neurosci Res. 48:1997;18-30.
43. Lachmund A., Gehrke D., Krieglstein K., Unsicker K. Trophic factors from chromaffin granules promote survival of peripheral and central nervous system neurons. Neuroscience. 62:1994;361-370.
44. Madrazo I., Drucker-Colin R., Diaz V., Martinez-Mata J., Torres C., Becerril J.J. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N Engl J Med. 316:1987;831-834.
45. Mayhew T.M. A review of recent advances in stereology for quantifying neural structure. J Neurocytol. 21:1992;313-328.
46. McTigue M., Cremins J., Halegoua S. Nerve growth factor and other agents mediate phosphorylation and activation of tyrosine hydroxylase A convergence of multiple kinase activities. J Biol Chem. 260:1985;9047-9056.
47. Mishima K., Higashiyama S., Nagashima Y., Miyagi Y., Tamura A., Kawahara N., Taniguchi N., Asai A., Kuchino Y., Kirino T. Regional distribution of heparin-binding epidermal growth factor-like growth factor mRNA in protein in adult rat forebrain. Neurosci Lett. 213:1996;153-156.
48. Nakagawa T., Sasahara M., Hayase Y., Haneda M., Yasuda H., Kikkawa R., Higashiyama S., Hazama F. Neuronal and glial expression of heparin-binding EGF-like growth factor in central nervous system of prenatal and early postnatal rat. Dev Brain Res. 108:1998;263-272.
49. Nishino H., Ono T., Shibata R., Kawamata S., Watanabe H., Shiosaka S., Tohyama M., Karadi Z. Adrenal medullary cells transmute into dopaminergic neurons in dopamine-depleted rat caudate and ameliorate motor disturbances. Brain Res. 445:1988;325-337.
50. O'Connor D.T. Chromaffin cell mechanisms Understanding catecholamine storage and release. Trends Pharmacol Sci. 20:1999;431-432.
51. Olanow C.W., Koller W.C., Goetz C.G., Stebbins G.T., Cahill D.W., Gauger L.L., Morantz R., Penn R.D., Tanner C.M., Klawans H.L. Autologous transplantation of adrenal medulla in Parkinson's disease 18-month results. Arch Neurol. 47:1990;1286-1289.
52. Opanashuk L.A., Mark R.J., Porter J., Damn D., Mattson M.P., Seroogy K.B. Heparin-binding epidermal growth factor-like growth factor in hippocampus Modulation of expression by seizures and anti-excitotoxic action. J Neurosci. 19:1999;133-146.
53. Pellegrino L.J., Pellegrino A.S., Cushman A.J. A stereotaxic atlas of the rat brain. 1979;Plenum Press, New York.
54. Raab G., Klagsbrun M. Heparin-binding EGF-like growth factor. Biochim Biophys Acta. 1333:1997;F179-F199.
55. Shing Y., Christofori G., Hanahan D., Ono Y., Sasada R., Igarashi K., Folkman J. Betacullin A mitogen from pancreatic b cell tumours. Science. 259:1993;1604-1607.
56. Shoyab M., Plowman G.D., McDonald V.L., Bradley J.G., Todaro G.J. Structure and function of human amphiregulin A member of the epidermal growth factor family. Science. 243:1989;1074-1076.
57. Sibilia M., Steinbach J.P., Stingl L., Aguzzi A., Wagner E.F. A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor. EMBO J. 17:1998;719-731.
58. Simpson D.L., Morrison R., de Vellis J., Herschman H.R. Epidermal growth factor binding and mitogenic activity on purified populations of cells from the central nervous system. J Neurosci Res. 8:1982;453-462.
59. Strelau J., Sullivan A., Bottner M., Lingor P., Falkenstein E., Suter-Crazzolara C., Galter D., Jaszai J., Krieglstein K., Unsicker K. Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. J Neurosci. 20:2000;8597-8603.
60. Stromberg I., Herrera-Marschitz M., Ungerstedt U., Ebendal T., Olson L. Chronic implants of chromaffin tissue into the dopaminergic-denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behavior. Exp Brain Res. 60:1985;335-349.
61. Sullivan A.M., Opacka-Juffry J., Blunt S.B. Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo. Eur J Neurosci. 10:1998;57-63.
62. Sullivan A.M., Pohl J., Blunt S.B. Growth/differentiation factor 5 and glial cell line-derived neurotrophic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson's disease. Eur J Neurosci. 10:1998;3681-3688.
63. Sullivan A.M., Opacka-Juffry J., Pohl J., Blunt S.B. Neuroprotective effects of growth/differentiation factor 5 depend on the site of administration. Brain Res. 818:1999;176-179.
64. Tanaka N., Sasahara M., Ohno M., Higashiyama S., Hayase Y., Shimada M. Heparin-binding epidermal growth factor-like growth factor mRNA expression in neonatal rat brain with hypoxic/ischemic injury. Brain Res. 827:1999;130-138.
65. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W-improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl Acid Res. 22:1994;4673-4680.
66. Unsicker K. The trophic cocktail made by adrenal chromaffin cells. Exp Neurol. 123:1993;167-173.
67. Unsicker K., Krieglstein K. Growth factors in chromaffin cells. Prog Neurobiol. 48:1996;307-324.
68. Werner M., Nanney L.B., Stoscheck C.M., King L.E. Localization of immunoreactive epidermal growth factor receptors in human nervous system. J Histochem Cytochem. 36:1988;81-86.
69. Winkler H, Smith AD (1975) The chromaffin granule and the storage of catecholamines. In: Handbook of physiology, section 7, Vol. 6 (Blaschko H, Smith AD, Sayers G, eds), pp 321-339.